NCT04712851 2026-03-10
Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia
Jonsson Comprehensive Cancer Center
Phase 2 Recruiting
Clinical Trials
42 trialsNCT07454915 2026-03-09
PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia
PapiVax Biotech, Inc.
Phase 2 Not yet recruiting
NCT06519994 2025-12-17
Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya
UNC Lineberger Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT04098744 2025-10-02
ART-CIN_IIB
Frantz Viral Therapeutics, LLC
Phase 2 Recruiting
NCT03267680 2025-04-13
IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3
University of Southern California
Phase 2 Terminated
NCT06525870 2024-11-14
Trichlosil
Department of Medical Services Ministry of Public Health of Thailand
Phase 2 Enrolling by invitation
NCT02864147 2024-05-02
Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)
Yale University
Phase 2 Completed
NCT03549273 2024-02-07
Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions
Catalysis SL
Phase 2 Unknown
NCT02481414 2023-12-18
A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions
University of Arkansas
Phase 2 Completed
NCT06015854 2023-08-29
Vvax
University Medical Center Groningen
Phase 2 Unknown
NCT02740777 2023-04-13
Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females
Shanghai Zerun Biotechnology Co.,Ltd
Phase 2 Completed
NCT04650711 2020-12-03
Immunohistochemical Staining of p16 for the Screening of Cervical Cancer
Peking Union Medical College Hospital
Phase 2 Unknown
NCT01925378 2020-11-12
A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia
The University of Texas Health Science Center, Houston
Phase 2 Withdrawn
NCT01928225 2020-06-24
Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL
University of Witwatersrand, South Africa
Phase 2 Completed
NCT02631863 2019-07-08
Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Phase 2 Completed
NCT01094132 2019-07-05
MDC_Algo
British Columbia Cancer Agency
Phase 2 Completed
NCT02304770 2019-06-12
Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Phase 2 Completed
NCT03745846 2018-11-19
A Efficacy and Safety Study of Composite Gel Containing Black Raspberry Extract in Removing HPV From Patients With Cervical Intraepithelial Neoplasia(CIN) After Cervical Conization
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT00006079 2018-10-25
Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
M.D. Anderson Cancer Center
Phase 2 Completed
NCT03469531 2018-08-13
Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Zhujiang Hospital
Phase 2 Unknown
NCT00075569 2018-05-21
SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia
Albert Einstein College of Medicine
Phase 2 Completed
NCT02576561 2017-10-25
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
THEVAX Genetics Vaccine
Phase 2 Unknown
NCT03143491 2017-10-18
Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN)
DFB Soria, LLC
Phase 2 Withdrawn
NCT03293628 2017-09-28
Comparing Two Techniques of Haemostasis After Cervical Conization
Barretos Cancer Hospital
Phase 2 Completed
NCT02139267 2017-07-12
Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia
Genexine, Inc.
Phase 2 Completed
NCT02596243 2017-07-12
Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E)
Genexine, Inc.
Phase 2 Unknown
NCT00312286 2016-09-23
Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
Takeda
Phase 2 Terminated
NCT00117884 2016-08-19
Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
Takeda
Phase 2 Terminated
NCT01022346 2016-08-15
A Study of RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With High Risk Human Papillomavirus (HR-HPV) Infection
Hoffmann-La Roche
Phase 2 Completed
NCT01116245 2016-07-27
ADXS11-001
Advaxis, Inc.
Phase 2 Terminated
NCT01826045 2016-01-29
PGA
BioLeaders Corporation
Phase 2 Completed
NCT01356823 2016-01-05
Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine
Xiamen University
Phase 2 Completed
NCT00703196 2015-10-08
Folic Acid Clinical Trial for the Prevention of Cervical Cancer
University of Alabama at Birmingham
Phase 2 Completed
NCT01405768 2014-07-28
Buffered Lidocaine for Loop Electrosurgical Excision Procedures (LEEPs)
Washington University School of Medicine
Phase 2 Completed
NCT02184975 2014-07-09
Cold Knife Conization With and Without Lateral Hemostatic Sutures
Barretos Cancer Hospital
Phase 2 Completed
NCT00072540 2013-11-08
S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix
SWOG Cancer Research Network
Phase 2 Withdrawn
NCT00060099 2013-11-06
SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01303328 2013-02-18
Colvir-PhaseII
Mithra Pharmaceuticals
Phase 2 Completed
NCT00054041 2013-01-24
Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
National Cancer Institute (NCI)
Phase 2 Completed
NCT00247169 2012-03-09
Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II
Medical University of Vienna
Phase 2 Completed
NCT00285207 2010-10-11
Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
Tigris Pharmaceuticals
Phase 2 Completed
NCT00596258 2009-05-22
TG-003
Tigris Pharmaceuticals
Phase 2 Completed